Please assess the completion status of the following clinical trial:

Trial Title: Nebulized PL for Post-COVID-19 Syndrome

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Voluntary signature of the IRB approved Informed Consent~2. At least 4-weeks post ventilator or oxygen dependent ARDS treated for at least 48 hours in the ICU~3. Patient is stable enough to have been discharged home~4. Male or female ages 18-85~5. Two weeks to 1-year post hospital discharge~6. Ongoing activity intolerance due to dyspnea related to ARDS~7. Is independent, ambulatory, and can comply with all post-operative evaluations and visits~8. 6-minute walk test distance of \< 450 M~9. SF-36 physical component score \< 60~10. ARDS caused by viral pneumonia including COVID-19 confirmed through an RNA anti-body test~11. Normal to mild post-ARDS reactive airway disease~Exclusion Criteria:~1. Oxygen dependent on nasal canula greater than 2-L per minute~2. Dependent on inhaled corticosteroid at the discretion of the physician~3. Unable to complete any of the outcomes measured (Spirometry, 6MWD, SF-36, etc.)~4. Active known secondary bacterial or viral infection~5. Active moderate or severe post-ARDS reactive airway disease at the discretion of the physician~6. Pre-morbid COPD~7. Medication list will be reviewed on a case by case basis to allow for flexibility as post-COVID-19 patients' medication list may vary~8. Other medical comorbidities/conditions that may preclude participation in the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Platelet Lysate (Type: EXPERIMENTAL): Inhaled nebulized platelet lysate (PL), 2-ml 1x per day for 8 weeks.
- Saline (Type: ACTIVE_COMPARATOR): Inhaled nebulized normal sterile saline, 2-ml 1x per day for 8-weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).